Deutsche Bank
CCCC icon

Deutsche Bank’s C4 Therapeutics CCCC Stock Holding History

Deutsche Bank’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$462K Buy
+98,873
New +$338K ﹤0.01% 2820
2025
Q2 		– Sell
-46,225
Closed -$74K – 3626
2025
Q1 		$74K Buy
+46,225
New +$138K ﹤0.01% 3291
2024
Q4 		– Sell
-39,180
Closed -$223K – 3622
2024
Q3 		$223K Buy
39,180
+9,332
+31% +$56.2K ﹤0.01% 2882
2024
Q2 		$138K Buy
+29,848
New +$178K ﹤0.01% 3002
2023
Q2 		– Sell
-25,932
Closed -$81.4K – 3827
2023
Q1 		$81.4K Buy
25,932
+8,162
+46% +$48.1K ﹤0.01% 3412
2022
Q4 		$105K Buy
17,770
+281
+2% +$2.33K ﹤0.01% 3308
2022
Q3 		$153K Sell
17,489
-939
-5% -$9.75K ﹤0.01% 3099
2022
Q2 		$139K Sell
18,428
-8,562
-32% -$75.3K ﹤0.01% 3356
2022
Q1 		$654K Sell
26,990
-29,050
-52% -$705K ﹤0.01% 2593
2021
Q4 		$1.8M Buy
56,040
+31,854
+132% +$1.26M ﹤0.01% 2064
2021
Q3 		$1.08M Buy
24,186
+2,327
+11% +$99.7K ﹤0.01% 2561
2021
Q2 		$828K Buy
21,859
+14,645
+203% +$525K ﹤0.01% 2893
2021
Q1 		$267K Sell
7,214
-648
-8% -$25.8K ﹤0.01% 3473
2020
Q4 		$260K Buy
+7,862
New +$228K ﹤0.01% 3323

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Deutsche Bank's CCCC Position: Q2 2026 in Review

Deutsche Bank opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 98,873 shares worth $462K. The stake represents ﹤0.01% of the portfolio and ranks #2820 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in CCCC as recently as Q1 2025.

Deutsche Bank first reported a position in CCCC in Q4 2020 and has held it in 14 quarters since. The position peaked at $1.8M in Q4 2021. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Deutsche Bank held 98,873 shares of C4 Therapeutics worth $462K as of Q2 2026.
  • C4 Therapeutics was a new Deutsche Bank position in Q2 2026.
  • C4 Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2820 holding.
  • Deutsche Bank first reported a position in C4 Therapeutics in Q4 2020 and has held it in 14 quarters since.
  • Deutsche Bank's C4 Therapeutics position peaked at $1.8M in Q4 2021.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.